Efficacy and Safety of Ixekizumab in a Randomized, Double-Blinded, Placebo-Controlled, Phase 3b Clinical Trial in Patients with Moderate-to-Severe Genital Psoriasis. J of Skin [Internet]. 2018 Feb. 23 [cited 2025 Jul. 22];2(S1):S8. Available from: https://skin.dermsquared.com/skin/article/view/285